Fagosept (20 Tablets)

Fagosept

Composition of 1 tablet:

Intestibacteriophage titer 10⁴, yeast cells 10⁴

Inactive substances: L-lactose 0.1 g, talc – 0.04 g, calcium stearate 0.09 g, cocoa powder 0.07 g.

Also see: Phagest 20 ml, 4 vials.

Field of use and recommendations for use

Phagosept is a parapharmaceutical product and is used as a biological agent against diarrhea, intestinal inflammation, and infections, as an anti-diarrheal microorganism-based product.

The intestibacteriophage contained in Phagosept destroys pathogenic microbes that cause infection, while live yeast cells have antimicrobial and antitoxic effects. The preparation stimulates the secretion of immunoglobulin IgA in the intestines, thereby increasing the body’s antimicrobial status and stimulating the synthesis of B-group vitamins in the body. Phagosept prevents the spread of various pathogenic and conditionally pathogenic microbes in the human body, the formation of inflammatory foci, increases the body’s nonspecific resistance, cleanses the body, strengthens immunity, and regulates metabolism.

Phagosept, as a prophylactic and supportive agent for normalizing intestinal microflora, is used in the following conditions: acute and chronic gastroenterocolitis, salmonellosis, dysentery, intestinal dysfunction, diarrhea, and constipation.

It is not a medicinal product and does not contain genetically modified organisms.

Method of administration:

To be taken after meals: for children, one tablet 1–2 times a day; for adults, one tablet 3 times a day.

The duration of intake ranges from 14 to 21 days, depending on the general condition.

Dosage in children:

• In children under 2 years of age – one tablet is dissolved (full dissolution time is 5 minutes) in lukewarm boiled water or breast milk and taken after meals once or twice a day.
• In children from 2 years of age – one tablet is taken after meals once or twice a day.

Overdose:

No cases of overdose have been reported.

Contraindications:

None.

Side effects:

Individual intolerance to the components.

Precautions and special instructions:

None required.

Pregnancy and lactation:

Use is permitted during pregnancy and breastfeeding.

Effect on drivers and personnel operating potentially dangerous machinery:

There is no data on any negative impact of the product on drivers or technical personnel.

Instructions regarding missed dose:

If a dose is missed, treatment should continue as usual without doubling the missed dose.

Interactions with other medicinal products and other forms of interaction:

Phagosept should not be taken together with antifungal medications, as its activity will be suppressed.

If visual inspection shows damage to the tablet, the product should not be used.

Storage conditions:

Store in a dry place, protected from light, at room temperature not exceeding 25°C.

Shelf life:

5 years.

Form of release:

20 tablets in a polyethylene vial placed in a cardboard box together with instructions.